UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | W | Z
Number of items: 190.

A

Ahmed, Z; Asi, YT; Sailer, A; Lees, AJ; Houlden, H; Revesz, T; Holton, JL; (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (1) pp. 4-24. 10.1111/j.1365-2990.2011.01234.x.

Ahmed, Z; Revesz, T; Holton, JL; (2012) Neuropathology and pathophysiology of multiple system atrophy Response. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (4) 381 - 381. 10.1111/j.1365-2990.2012.01266.x.

Ahmed, Z; Revesz, T; Holton, JL; (2012) Neuropathology and pathophysiology of multiple system atrophy Response. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (4) p. 381. 10.1111/j.1365-2990.2012.01266.x.

Alner, K; Hyare, H; Mead, S; Rudge, P; Wroe, S; Rohrer, JD; Ridgway, GR; (2012) Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (1) pp. 109-114. 10.1136/jnnp-2011-300167.

Anderson, VM; Schott, JM; Bartlett, JW; Leung, KK; Miller, DH; Fox, NC; (2012) Gray matter atrophy rate as a marker of disease progression in AD. NEUROBIOLOGY OF AGING , 33 (7) pp. 1194-1202. 10.1016/j.neurobiolaging.2010.11.001.

Andre, R; Tabrizi, SJ; (2012) Misfolded PrP and a novel mechanism of proteasome inhibition. PRION , 6 (1) pp. 32-36. 10.4161/pri.6.1.18272.

Andre, R; Tabrizi, SJ; (2012) Misfolded PrP and a novel mechanism of proteasome inhibition. Prion , 6 (1) pp. 32-36. 10.4161/pri.6.1.18272.

Andre, R; Weiss, A; Traeger, U; Grueninger, S; Farmer, R; Landles, C; Scahill, R; (2012) MUTANT HUNTINGTIN FRAGMENTATION IN IMMUNE CELLS TRACKS HUNTINGTON'S DISEASE PROGRESSION. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A22-A23). BMJ PUBLISHING GROUP

Andre, R; Wild, EJ; Tabrizi, SJ; (2012) Huntington's disease: fighting on many fronts. BRAIN , 135 pp. 998-1001. 10.1093/brain/aws060.

B

Bartlett, JW; Frost, C; Mattsson, N; Skillbaeck, T; Blennow, K; Zetterberg, H; Schott, JM; (2012) Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. BIOMARKERS IN MEDICINE , 6 (4) pp. 391-400. 10.2217/BMM.12.49.

Bateman, RJ; Xiong, C; Benzinger, TLS; Fagan, AM; Goate, A; Fox, NC; Marcus, DS; (2012) Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease. NEW ENGLAND JOURNAL OF MEDICINE , 367 (9) pp. 795-804. 10.1056/NEJMoa1202753.

Beck, J; Collinge, J; Mead, S; (2012) Prion protein gene M232R variation is probably an uncommon polymorphism rather than a pathogenic mutation. BRAIN , 135 (ARTN e20) 10.1093/brain/awr294.

Boccardi, M; Bocchetta, M; Apostolova, L; Barnes, J; Bartzokis, G; Corbetta, G; DeCarli, C; (2012) Delphi Consensus on Landmarks for the Manual Segmentation of the Hippocampus on MRI: Preliminary Results from the EADC-ADNI Harmonized Protocol Working Group. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Borowsky, B; Warner, J; Matson, W; Johnson, H; Durr, A; Roos, R; Tabrizi, SJ; (2012) 8OHDG IS NOT A BIOMARKER FOR HUNTINGTON'S DISEASE; LESSONS FOR FUTURE BIOMARKER STUDIES. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A25-A26). BMJ PUBLISHING GROUP

Bouchard, J; Truong, J; Bouchard, K; Dunkelberger, D; Desrayaud, S; Moussaoui, S; Tabrizi, SJ; (2012) Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease. JOURNAL OF NEUROSCIENCE , 32 (50) pp. 18259-18268. 10.1523/JNEUROSCI.4008-12.2012.

Bunton-Stasyshyn, R; Devoy, A; Fisher, EMC; (2012) An investigation into the role of endogenousmouse Sod1 in the disease course of transgenic SOD1mouse models of amyotrophic lateral sclerosis. In: (Proceedings) American Society of Neuroscience Annual meeting.

Bunton-Stasyshyn, R; Devoy, A; Tybulewicz, V; Fisher, EMC; (2012) A SOD1 humanising knock-in mouse model of ALS with conditional point mutation. In: (Proceedings) UCL Neuroscience Symposium.

C

Cardoso, MJ; Wolz, R; Modat, M; Fox, NC; Rueckert, D; Ourselin, S; (2012) Geodesic Information Flows. In: Ayache, N and Delingette, H and Golland, P and Mori, K, (eds.) (Proceedings) 15th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI). (pp. pp. 262-270). SPRINGER-VERLAG BERLIN

Carswell, C; Rañopa, M; Pal, S; Macfarlane, R; Siddique, D; Thomas, D; Webb, T; (2012) Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1. Dement Geriatr Cogn Dis Extra , 2 (1) pp. 286-297. Gold open access

Carswell, C; Thompson, A; Lukic, A; Stevens, J; Rudge, P; Mead, S; Collinge, J; (2012) MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC NEUROLOGY , 12 (ARTN 153) 10.1186/1471-2377-12-153. Gold open access

Cash, DM; Melbourne, A; Modat, M; Cardoso, MJ; Clarkson, MJ; Fox, NC; Ourselin, S; (2012) Cortical Folding Analysis on Patients with Alzheimer's Disease and Mild Cognitive Impairment. In: Ayache, N and Delingette, H and Golland, P and Mori, K, (eds.) (Proceedings) 15th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI). (pp. pp. 289-296). SPRINGER-VERLAG BERLIN

Castro-Seoane, R; Hummerich, H; Sweeting, T; Tattum, MH; Linehan, JM; Fernandez de Marco, M; Brandner, S; (2012) Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection. PLoS Pathogens , 8 (2) , Article e1002538. 10.1371/journal.ppat.1002538. Green open access
file

Chaminade, T; Marchant, JL; Kilner, J; Frith, CD; (2012) An fMRI study of joint action-varying levels of cooperation correlates with activity in control networks. FRONTIERS IN HUMAN NEUROSCIENCE , 6 (ARTN 179) 10.3389/fnhum.2012.00179.

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; Gentleman, SM; (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. NEUROBIOLOGY OF AGING , 33 (4) 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; Gentleman, SM; (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiology of Aging , 33 (4) 10.1016/j.neurobiolaging.2011.11.001.

Chen, CWR; Kachramanoglou, C; Revesz, T; Choi, D; (2012) Rosai-Dorfman disease presenting as a thoracic intradural extramedullary spinal tumor but without extraspinal manifestations. ACTA NEUROCHIRURGICA , 154 (2) pp. 367-368. 10.1007/s00701-011-1176-1.

Clark, CN; Weber, YW; Lerche, H; Warner, TT; (2012) Paroxysmal exercise-induced dyskinesia of the hands. Mov Disord , 27 (12) pp. 1579-1580. 10.1002/mds.25200.

Cole, J; Rees, EM; Farmer, RE; Crawford, HE; Mueller, H-P; Sprengelmeyer, R; Frost, C; (2012) RELIABILITY OF DIFFUSION TENSOR IMAGING MEASURES. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A28-A28). BMJ PUBLISHING GROUP

Collinge, J; (2012) Prion propagation and its wider implications. PRION , 6 p. 1.

Collinge, J; (2012) The Risk of Prion Zoonoses. SCIENCE , 335 (6067) pp. 411-413. 10.1126/science.1218167.

Crawford, HE; Hobbs, NZ; Cole, J; Rees, EM; Owen, G; Langbehn, DR; Frost, C; (2012) CORPUS CALLOSAL ATROPHY IN HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A27-A27). BMJ PUBLISHING GROUP

Crutch, S; Lehmann, M; Warrington, EK; Warren, JD; Rohrer, JD; (2012) PARIETAL CONTRIBUTIONS TO LANGUAGE PROCESSING: PROGRESSIVE APHASIA IN POSTERIOR CORTICAL ATROPHY. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Crutch, SJ; Lehmann, M; Schott, JM; Rabinovici, GD; Rossor, MN; Fox, NC; (2012) Posterior cortical atrophy. Lancet Neurology , 11 (2) 170 - 178. 10.1016/S1474-4422(11)70289-7. Green open access
file

Crutch, SJ; Ridgway, GR; (2012) On the semantic elements of abstract words. Cortex , 48 (10) pp. 1376-1378. 10.1016/j.cortex.2012.05.010.

Crutch, SJ; Williams, P; Ridgway, GR; Borgenicht, L; (2012) The role of polarity in antonym and synonym conceptual knowledge: Evidence from stroke aphasia and multidimensional ratings of abstract words. NEUROPSYCHOLOGIA , 50 (11) pp. 2636-2644. 10.1016/j.neuropsychologia.2012.07.015.

D

Davidson, GL; Murphy, SM; Polke, JM; Laura, M; Salih, MAM; Muntoni, F; Blake, J; (2012) Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. JOURNAL OF NEUROLOGY , 259 (8) pp. 1673-1685. 10.1007/s00415-011-6397-y.

Devoy, A; Bunton-Stasyshyn, RKA; Tybulewicz, VLJ; Smith, AJH; Fisher, EMC; (2012) Genomically humanized mice: technologies and promises. NATURE REVIEWS GENETICS , 13 (1) pp. 14-20. 10.1038/nrg3116.

Downey, LE; Mahoney, CJ; Rossor, MN; Crutch, SJ; Warren, JD; (2012) Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion. ALZHEIMERS RESEARCH & THERAPY , 4 (5) 10.1186/alzrt145. Gold open access

Dumas, EM; Say, MJ; Jones, R; Labuschagne, I; O'Regan, AM; Hart, EP; van den Bogaard, SJ; (2012) Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease. J Huntingtons Dis , 1 (1) pp. 97-106. 10.3233/JHD-2012-120010.

Dumas, EM; van den Bogaard, SJA; Ruber, ME; Reilman, RR; Stout, JC; Craufurd, D; Hicks, SL; (2012) Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. HUMAN BRAIN MAPPING , 33 (1) pp. 203-212. 10.1002/hbm.21205.

E

Englund, E; Gustafson, L; Passant, U; Majounie, E; Renton, AE; Traynor, BJ; Rohrer, JD; (2012) Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. NEUROBIOLOGY OF AGING , 33 (8) 10.1016/j.neurobiolaging.2012.02.019.

F

Farmer, M; Kloehn, P; Linehan, J; O'Malley, C; de Marco, MF; Taylor, W; Farrow, M; (2012) PrP antibodies do not trigger mouse hippocampal neuron apoptosis. PRION , 6 p. 102.

Filippi, M; Agosta, F; Barkhof, F; Dubois, B; Fox, NC; Frisoni, GB; Jack, CR; (2012) EFNS task force: the use of neuroimaging in the diagnosis of dementia. EUROPEAN JOURNAL OF NEUROLOGY , 19 (12) 1487-E140. 10.1111/j.1468-1331.2012.03859.x.

Fonteijn, HM; Modat, M; Clarkson, MJ; Barnes, J; Lehmann, M; Hobbs, NZ; Scahill, RI; (2012) An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. NEUROIMAGE , 60 (3) pp. 1880-1889. 10.1016/j.neuroimage.2012.01.062.

Fox, N; (2012) MRI IN THE EVALUATION OF THERAPEUTIC EFFECTS IN CLINICAL TRIALS IN EARLY AND PRESYMPTOMATIC AD. In: (Proceedings) 12th International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. (pp. S10-S11). ELSEVIER SCIENCE INC

Fox, N; (2012) When, where, and how does Alzheimer's disease start? LANCET NEUROLOGY , 11 (12) pp. 1017-1018. 10.1016/S1474-4422(12)70256-9.

Fratta, P; Mizielinska, S; Nicoll, AJ; Zloh, M; Fisher, EM; Parkinson, G; Isaacs, AM; (2012) C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Scientific Reports , 2 , Article 1016. 10.1038/srep01016. Green open access
filefilefilefilefilefile

Frost, C; Jones, R; Labuschange, I; Say, M; Justo, D; Coleman, A; Dumas, E; (2012) THE POTENTIAL OF A COMPOSITE COGNITIVE SCORE FOR TRACKING PROGRESSION IN HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A36-A36). BMJ PUBLISHING GROUP

G

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; Sims, R; (2012) The Role of Variation at A beta PP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE , 28 (2) pp. 377-387. 10.3233/JAD-2011-110824.

Ghazi-Noori, S; Froud, KE; Mizielinska, S; Powell, C; Smidak, M; de Marco, MF; O'Malley, C; (2012) Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. BRAIN , 135 pp. 819-832. 10.1093/brain/aws006.

Ghosh, R; Docherty, E; Schickerling, S; Heinz, P; Campbell-Hewson, G; Boyle, A; (2012) Application of the 2007 NICE guidelines in the management of paediatric minor head injuries in a UK emergency department. EMERGENCY MEDICINE JOURNAL , 29 (3) pp. 197-200. 10.1136/emj.2009.085639.

Giunti, P; Houlden, H; Gardner-Thorpe, C; Worth, PF; Johnson, J; Hilton, DA; Revesz, T; (2012) Spinocerebellar ataxia type 11. In: UNSPECIFIED (pp. 521-534).

Goll, JC; Kim, LG; Ridgway, GR; Hailstone, JC; Lehmann, M; Buckley, AH; Crutch, SJ; (2012) Impairments of auditory scene analysis in Alzheimer's disease. Brain , 135 (Pt 1) pp. 190-200. 10.1093/brain/awr260. Gold open access

Goll, JC; Ridgway, GR; Crutch, SJ; Theunissen, FE; Warren, JD; (2012) Nonverbal sound processing in semantic dementia: A functional MRI study. NEUROIMAGE , 61 (1) pp. 170-180. 10.1016/j.neuroimage.2012.02.045.

Griffiths, TD; Bamiou, DE; Warren, JD; (2012) Disorders of the auditory brain. In: The Oxford Handbook of Auditory Science The Auditory Brain.

Grizenkova, J; Akhtar, S; Hummerich, H; Tomlinson, A; Asante, EA; Wenborn, A; Fizet, J; (2012) Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 109 (34) pp. 13722-13727. 10.1073/pnas.1208917109. Gold open access

H

Haas, M; Watson-Scales, S; Slender, A; Fisher, EMC; Tybulewicz, V; Guillemot, F; (2012) Understanding Down syndrome using the Tc1 mouse model. In: (Proceedings) Australian Neuroscience Society.

Haider, S; Andre, R; Farmer, R; Suessmuth, S; Frost, C; Bjorkqvist, M; Westerberg, G; (2012) SIRT 1 MEDIATED MODULATION OF CIRCULATING CYTOKINES IN HUNTINGTON'S DISEASE-PHARMACODYNAMICS RESULTS FROM PHASE 1B STUDY OF SELISISTAT-A SIRT 1 INHIBITOR. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A54-A55). BMJ PUBLISHING GROUP

Haider, SS; Landwehrmeyer, BG; Sissumuth, SD; Frost, C; Farmer, R; Andre, R; Caricasole, A; (2012) FROM BIOLOGY TO THE BEDSIDE-SIRTUINS AS TARGETS FOR DISEASE MODIFICATION IN HUNTINGTON'S DISEASE: SELISISTAT PRECLINICAL DATA AND PRELIMINARY PHASE I RESULTS. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Haider, SS; Landwehrmeyer, BG; Sissumuth, SD; Frost, C; Farmer, R; Andre, R; Caricasole, A; (2012) FROM BIOLOGY TO THE BEDSIDE-SIRTUINS AS TARGETS FOR DISEASE MODIFICATION IN HUNTINGTON'S DISEASE: SELISISTAT PRECLINICAL DATA AND PRELIMINARY PHASE I RESULTS. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Hailstone, JC; Ridgway, GR; Bartlett, JW; Goll, JC; Crutch, SJ; Warren, JD; (2012) Accent processing in dementia. Neuropsychologia , 50 (9) pp. 2233-2244. 10.1016/j.neuropsychologia.2012.05.027. Green open access
file

Hardy, J; Revesz, T; (2012) The Spread of Neurodegenerative Disease. NEW ENGLAND JOURNAL OF MEDICINE , 366 (22) pp. 2126-2128.

Hicks, S; Scahill, RI; Dumas, E; Durr, A; Blair, R; Levitt, BR; Roos, RAC; (2012) OCULOMOTOR DEFICITS IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES: THE LONGITUDINAL TRACK-HD STUDY. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Hobbs, NZ; Cole, J; Farmer, RE; Rees, EM; Scahill, RI; Crawford, HE; Roos, RAC; (2012) EVALUATION OF MULTI-MODAL, MULTI-SITE IMAGING MEASURES IN HUNTINGTON'S DISEASE: BASELINE RESULTS FROM THE PADDINGTON STUDY. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A26-A26). BMJ PUBLISHING GROUP

Holl, AK; Wilkinson, L; Tabrizi, SJ; Painold, A; Jahanshahi, M; (2012) Probabilistic classification learning with corrective feedback is selectively impaired in early Huntington's disease--evidence for the role of the striatum in learning with feedback. Neuropsychologia , 50 (9) pp. 2176-2186. 10.1016/j.neuropsychologia.2012.05.021.

Holmes, H; Wells, J; O'Callaghan, J; Richardson, S; Siow, B; Powell, N; Da, M; (2012) Morphometric genomics: in vivo midro MRI for 3D structural imaging of transgenic mice. In: (Proceedings) International Society for Magnetic Resonance in Medicine British Chapter.

Hyare, H; Ramlackhansingh, A; Gelosa, G; Edison, P; Rudge, P; Brandner, S; Brooks, DJ; (2012) 11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry , 83 (3) pp. 340-341. 10.1136/jnnp.2010.233692.

Hyare, H; Ramlackhansingh, A; Gelosa, G; Edison, P; Rudge, P; Brandner, S; Brooks, DJ; (2012) C-11-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (3) pp. 340-341.

I

Ingram, CJE; Weale, ME; Plaster, CA; Morrison, KE; Goodall, EF; Pall, HS; Beck, M; (2012) Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS , 13 (4) pp. 341-346. 10.3109/17482968.2012.654394.

J

Jaffer, F; Murphy, SM; Scoto, M; Healy, E; Rossor, AM; Brandner, S; Phadke, R; (2012) BAG3 mutations: another cause of giant axonal neuropathy. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , 17 (2) pp. 210-216. 10.1111/j.1529-8027.2012.00409.x.

Johannsen, P; Roos, P; Law, I; Frahm-Falkenberg, S; Isaacs, A; Brown, J; Nielsen, JE; (2012) Changes in Cerebral Glucose Metabolism in Early Symptomatic Frontotemporal Dementia Linked to Chromosome 3 (FTD-3). In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. pp. 130-131). KARGER

Johnson, KA; Fox, NC; Sperling, RA; Klunk, WE; (2012) Brain Imaging in Alzheimer Disease. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE , 2 (4) 10.1101/cshperspect.a006213.

Johnson, KA; Fox, NC; Sperling, RA; Klunk, WE; (2012) Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med , 2 (4) a006213-. 10.1101/cshperspect.a006213.

K

Kara, E; Ling, H; Pittman, AM; Shaw, K; de Silva, R; Simone, R; Holton, JL; (2012) The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobioly of Aging , 33 (9) 2231.e7 - 2231.e14. 10.1016/j.neurobiolaging.2012.04.006. Green open access
file

Keihaninejad, S; Ryan, NS; Malone, IB; Modat, M; Cash, D; Ridgway, GR; Zhang, H; (2012) The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease. PLOS One , 7 (11) , Article e45996. 10.1371/journal.pone.0045996. Green open access
file

Keller, MF; Saad, M; Bras, J; Bettella, F; Nicolaou, N; Simon-Sanchez, J; Mittag, F; (2012) Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. HUMAN MOLECULAR GENETICS , 21 (22) pp. 4996-5009. 10.1093/hmg/dds335.

Kennedy, J; Lehmann, M; Sokolska, MJ; Archer, H; Warrington, EK; Fox, NC; Crutch, SJ; (2012) Visualizing the emergence of posterior cortical atrophy. NEUROCASE , 18 (3) pp. 248-257. 10.1080/13554794.2011.588180.

Kloehn, P; Castro-Seoane, R; Hummerich, H; Sweeting, T; Tattum, H; Linehan, J; de Marco, MF; (2012) Plasmacytoid dendritic cells sequester high prion titers at early stages of prion infection. In: (pp. p. 7). LANDES BIOSCIENCE

Kloehn, P-C; Farmer, M; Linehan, JM; O'Malley, C; de Marco, MF; Taylor, W; Farrow, M; (2012) PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis. SCIENCE , 335 (6064) p. 52. 10.1126/science.1215579.

Koiava, N; Ong, YH; Brown, MM; Acheson, J; Plant, GT; Leff, AP; (2012) A 'web app' for diagnosing hemianopia. Journal of Neurology, Neurosurgery and Psychiatry , 83 (12) pp. 1222-1224. 10.1136/jnnp-2012-302270.

Kotting, P; Beicher, K; McKeith, IG; Rossor, MN; (2012) Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network. Alzheimers Res Ther , 4 (4) 23-. 10.1186/alzrt126. Gold open access

Kwan, W; Magnusson, A; Chou, A; Adame, A; Carson, MJ; Kohsaka, S; Masliah, E; (2012) Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease. JOURNAL OF NEUROSCIENCE , 32 (1) pp. 133-142. 10.1523/JNEUROSCI.4846-11.2012.

Kwan, W; Traeger, U; Davalos, D; Chou, A; Bouchard, J; Andre, R; Miller, A; (2012) Mutant huntingtin impairs immune cell migration in Huntington disease. JOURNAL OF CLINICAL INVESTIGATION , 122 (12) pp. 4737-4747. 10.1172/JCI64484.

L

Lahmann, C; Henningsen, P; Dieterich, M; Feuerecker, R; Cyran, CA; Schmid, G; (2012) The Munich Diagnostic and Predictor Study of Dizziness: objectives, design, and methods. Journal of Neurology , 259 (4) pp. 702-711. 10.1007/s00415-011-6250-3.

Lee, JM; Ramos, EM; Lee, JH; Gillis, T; Mysore, JS; Hayden, MR; Warby, SC; (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology , 78 (10) pp. 690-695. 10.1212/WNL.0b013e318249f683.

Lehmann, M; Barnes, J; Ridgway, GR; Ryan, NS; Warrington, EK; Crutch, SJ; Fox, NC; (2012) Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimer's & Dementia , 8 (6) 502 - 512. 10.1016/j.jalz.2011.09.225. Green open access
file

Lehmann, M; Koedam, EL; Barnes, J; Bartlett, JW; Ryan, NS; Pijnenburg, YA; Barkhof, F; (2012) Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiology of Disease , 33 (3) 627.e1 - 627.e12. 10.1016/j.neurobiolaging.2011.04.003. Green open access
file

Lehmann, M; Koedam, ELGE; Barnes, J; Bartlett, JW; Ryan, NS; Pijnenburg, YAL; Barkhof, F; (2012) Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiology of Aging , 33 (3) 10.1016/j.neurobiolaging.2011.04.003.

Leung, KK; Ridgway, GR; Ourselin, S; Fox, NC; Alzheimer's Disease Neuroimaging Initiative, ; (2012) Consistent multi-time-point brain atrophy estimation from the boundary shift integral. Neuroimage , 59 (4) 3995 - 4005. 10.1016/j.neuroimage.2011.10.068.

Ling, H; de Silva, R; Massey, L; Bajaj, N; Lowe, J; Holton, J; Lees, A; (2012) Clinicopathological correlation of progressive supranuclear palsy presenting with corticobasal syndrome. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 290). WILEY-BLACKWELL

Lunau, L; Mouridsen, K; Rodell, A; Ostergaard, L; Nielsen, JE; Isaacs, A; Johannsen, P; (2012) Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI. BMJ OPEN , 2 (2) 10.1136/bmjopen-2011-000368. Gold open access

M

Magnusson-Lind, A; Davidsson, M; Silajdzic, E; Hansen, C; Tabrizi, SJ; Bjorkqvist, M; (2012) DOES A PERIPHERAL IMMUNE RESPONSE INFLUENCE MUSCLE PATHOLOGY IN HUNTINGTON'S DISEASE? In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A12-A12). BMJ PUBLISHING GROUP

Mahoney, C; Rossor, MN; Fox, NC; Warren, JD; (2012) PROFILES OF WHITE MATTER DEGENERATION IN FRONTOTEMPORAL DEMENTIA. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Mahoney, CJ; Beck, J; Rohrer, JD; Lashley, T; Mok, K; Shakespeare, T; Yeatman, T; (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain , 135 (3) 736 - 750. 10.1093/brain/awr361. Green open access
file

Mahoney, CJ; Downey, LE; Ridgway, GR; Beck, J; Clegg, S; Blair, M; Finnegan, S; (2012) Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. ALZHEIMERS RESEARCH & THERAPY , 4 (5) 10.1186/alzrt144. Gold open access

Majounie, E; Renton, AE; Mok, K; Dopper, EG; Waite, A; Rollinson, S; Chiò, A; (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurology , 11 (4) 323 - 330. 10.1016/S1474-4422(12)70043-1. Green open access
file

Marchant, JL; Ruff, CC; Driver, J; (2012) Audiovisual synchrony enhances BOLD responses in a brain network including multisensory STS while also enhancing target-detection performance for both modalities. HUMAN BRAIN MAPPING , 33 (5) pp. 1212-1224. 10.1002/hbm.21278.

Marchant Agustus, JL; (2012) Audiovisual synchrony and temporal-pattern effects on human perception and the human brain. Doctoral thesis, UCL (University College London).

Massey, LA; Micallef, C; Paviour, DC; O'Sullivan, SS; Ling, H; Williams, DR; Kallis, C; (2012) Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders , 27 (14) 1754 - 1762. 10.1002/mds.24968.

Massey, LA; Miranda, MA; Zrinzo, L; Al-Helli, O; Parkes, HG; Thornton, JS; So, P-W; (2012) High resolution MR anatomy of the subthalamic nucleus: Imaging at 9.4 T with histological validation. NEUROIMAGE , 59 (3) pp. 2035-2044. 10.1016/j.neuroimage.2011.10.016.

Massey, LA; Miranda, MA; Zrinzo, L; Al-Helli, O; Parkes, HG; Thornton, JS; So, PW; (2012) High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage , 59 (3) pp. 2035-2044. 10.1016/j.neuroimage.2011.10.016.

McGoldrick, P; Joyce, P; Acevedo-Arozena, A; Fisher, E; Greensmith, L; (2012) Investigating new mutant models of MND. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S13-S13). PERGAMON-ELSEVIER SCIENCE LTD

McNaughton, D; Knight, W; Guerreiro, R; Ryan, N; Lowe, J; Poulter, M; Nicholl, DJ; (2012) Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobioly of Aging , 33 (2) 426.e13 - 426.e21. 10.1016/j.neurobiolaging.2010.10.010. Green open access
file

Mead, S; Beck, J; Poulter, M; Rohrer, J; Adamson, G; Hensman, D; Polke, J; (2012) Large C9ORF72 hexanucleotide expansions arise spontaneously in the healthy population but can be distinguished from pathogenic mutations by Sothern Blotting. In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. pp. 285-286). KARGER

Mead, S; Uphill, J; Beck, J; Poulter, M; Campbell, T; Lowe, J; Adamson, G; (2012) Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. HUMAN MOLECULAR GENETICS , 21 (8) pp. 1897-1906. 10.1093/hmg/ddr607.

Modat, M; Cardoso, MJ; Cash, DM; Leung, KK; Clarkson, MJ; Barnes, J; Fox, NC; (2012) A Pipeline for efficient segmentation using a large template library. Presented at: ECR 2012 EIBIR IMAGINE workshop, Vienna, Austria.

Modat, M; Cardoso, MJ; Daga, P; Cash, D; Fox, NC; Ourselin, S; (2012) Inverse-consistent symmetric free form deformation. In: (pp. pp. 79-88).

Modat, M; Leung, KK; Cardoso, MJ; Fox, NC; (2012) Atrophy Measurement Based on Segmentation Propagation and the Boundary Shift Integral Technique. In: Wang, L and Yushkevich, P and Ourselin, S, (eds.) NIBAD'12: MICCAI 2012 Workshop on Novel Imaging Biomarkers for Alzheimer's Disease and Related Disorders, October 5, 2012, Acropolis Convention Center, Nice, France. (pp. 266 - 274). CreateSpace Independent Publishing Platform Green open access
file

Morris, JC; Aisen, PS; Bateman, RJ; Benzinger, TL; Cairns, NJ; Fagan, AM; Ghetti, B; (2012) Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) , 2 (10) pp. 975-984. 10.4155/cli.12.93.

Mueller, H-P; Sprengelmeyer, R; Suessmuth, SD; Groen, G; Hobbs, NZ; Roos, RAC; Duerr, A; (2012) A MULTICENTRE APPROACH FOR THE DETECTION OF PATTERNS OF IMPAIRMENT IN HUNTINGTON'S DISEASE BY USING DIFFUSION TENSOR IMAGING. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A28-A29). BMJ PUBLISHING GROUP

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. J Neurol Neurosurg Psychiatry , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

N

Niccoli, T; Partridge, L; (2012) Ageing as a Risk Factor for Disease. CURRENT BIOLOGY , 22 (17) R741-R752. 10.1016/j.cub.2012.07.024.

Nielsen, TT; Hasholt, L; Isaacs, AM; Nielsen, JE; (2012) Reversal of Pathology in CHMP2B-Mediated Frontotemporal Dementia Patient Cells Using Gene Therapy. In: (Proceedings) 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S67-S67). NATURE PUBLISHING GROUP

Nielsen, TT; Mizielinska, S; Hasholt, L; Isaacs, AM; Nielsen, JE; (2012) Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference. JOURNAL OF GENE MEDICINE , 14 (8) pp. 521-529. 10.1002/jgm.2649.

Novak, M; Seunarine, K; Gibbard, C; Clark, C; Tabrizi, SJ; (2012) STRUCTURAL CONNECTIVITY-BASED TOPOGRAPHY OF THE BASAL GANGLIA IS ALTERED IN PREMANIFEST AND EARLY MANIFEST HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A29-A29). BMJ PUBLISHING GROUP

Novak, M; Warren, J; Henley, S; Draganski, B; Frackowiak, R; Tabrizi, SJ; (2012) DISTRIBUTED NEURAL NETWORKS ASSOCIATED WITH EMOTION PROCESSING ARE ALTERED IN PREMANIFEST HUNTINGTON'S DISEASE AND CORRELATED WITH GENETIC LOAD. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A39-A40). BMJ PUBLISHING GROUP

Novak, MJ; Warren, JD; Henley, SM; Draganski, B; Frackowiak, RS; Tabrizi, SJ; (2012) Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Brain , 135 (Pt 4) pp. 1165-1179. 10.1093/brain/aws024. Gold open access

O

Olsson, MG; Davidsson, S; Muhammad, ZD; Lahiri, N; Tabrizi, SJ; Akerstrom, B; Bjorkqvist, M; (2012) Increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease. Front Biosci (Elite Ed) , 4 pp. 950-957.

Omar, R; Hailstone, JC; Warren, JD; (2012) SEMANTIC MEMORY FOR MUSIC IN DEMENTIA. MUSIC PERCEPTION , 29 (5) pp. 467-477. 10.1525/MP.2012.29.5.467.

Ozawa, T; Revesz, T; Paviour, D; Lees, AJ; Quinn, N; Tada, M; Kakita, A; (2012) Difference in MSA Phenotype Distribution Between Populations: Genetics or Environment? JOURNAL OF PARKINSONS DISEASE , 2 (1) pp. 7-18. 10.3233/JPD-2012-11056.

P

Paisan-Ruiz, C; Li, A; Schneider, SA; Holton, JL; Johnson, R; Kidd, D; Chataway, J; (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. NEUROBIOLOGY OF AGING , 33 (4) pp. 814-823. 10.1016/j.neurobiolaging.2010.05.009.

Paterson, RW; Waldermar, G; Chaudhuri, KR; Varga, ET; Sztriha, LK; Sellner, J; Sauerbier, A; (2012) Career mentorship for young neurologists in Europe. Neurology , 79 (4) pp. 381-383. 10.1212/WNL.0b013e318260cdd7.

Paudel, R; Hardy, J; Revesz, T; Holton, JL; Houlden, H; (2012) Review: Genetics and neuropathology of primary pure dystonia. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (6) pp. 520-534. 10.1111/j.1365-2990.2012.01298.x.

Paudel, R; Hardy, J; Revesz, T; Holton, JL; Houlden, H; (2012) Review: Genetics and neuropathology of primary pure dystonia. Neuropathology and Applied Neurobiology , 38 (6) pp. 520-534. 10.1111/j.1365-2990.2012.01298.x.

Petrovic, IN; Ling, H; Asi, Y; Ahmed, Z; Kukkle, PL; Hazrati, L-N; Lang, AE; (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch. MOVEMENT DISORDERS , 27 (9) pp. 1184-1188. 10.1002/mds.25115.

Pope, BD; Chandra, T; Buckley, Q; Hoare, M; Ryba, T; Wiseman, FK; Kuta, A; (2012) Replication-timing boundaries facilitate cell-type and species-specific regulation of a rearranged human chromosome in mouse. HUMAN MOLECULAR GENETICS , 21 (19) pp. 4162-4170. 10.1093/hmg/dds232.

Porter, MC; Hyare, H; De Vita, E; Thompson, A; Lukic, A; Yousry, T; Rudge, P; (2012) VOXELWISE ANALYSIS OF CEREBRAL DIFFUSION TENSOR IMAGING IN PRION DISEASES. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Purro, SA; Dickins, EM; Salinas, PC; (2012) The Secreted Wnt Antagonist Dickkopf-1 Is Required for Amyloid beta-Mediated Synaptic Loss. JOURNAL OF NEUROSCIENCE , 32 (10) pp. 3492-3498. 10.1523/JNEUROSCI.4562-11.2012.

Q

Quarrell, OW; Handley, O; O'Donovan, K; Dumoulin, C; Ramos-Arroyo, M; Biunno, I; Bauer, P; (2012) Discrepancies in reporting the CAG repeat lengths for Huntington's disease. Eur J Hum Genet , 20 (1) pp. 20-26. 10.1038/ejhg.2011.136.

Quarterman, E; Pannell, M; Adams, N; Farrow, M; Collinge, J; (2012) High throughput screen of pharmacologically active compounds using chronically infected neuroblastoma (PK1) cells. PRION , 6 p. 102.

R

Read, J; Owen, G; Keogh, R; Busse, M; Jauffret, C; Coleman, A; 't Hart, E; (2012) EVALUATION OF LIFE TIME PHYSICAL ACTIVITY LEVELS IN HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A33-A33). BMJ PUBLISHING GROUP

Rees, EM; Hobbs, NZ; Farmer, RE; Henley, SMD; Haider, S; Scahill, RI; Tabrizi, SJ; (2012) COGNITIVE FUNCTIONS OF THE PUTAMEN IN HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A38-A38). BMJ PUBLISHING GROUP

Revesz, T; (2012) Update on tauopathies: pathological features. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 822). WILEY-BLACKWELL

Ridgway, GR; Lehmann, M; Barnes, J; Rohrer, JD; Warren, JD; Crutch, SJ; Fox, NC; (2012) Early-onset Alzheimer disease clinical variants Multivariate analyses of cortical thickness. NEUROLOGY , 79 (1) pp. 80-84. 10.1212/WNL.0b013e31825dce28. Gold open access

Rishal, I; Kam, N; Perry, R; Shinder, V; Fisher, EMC; Schiavo, G; Fainzilber, M; (2012) A motor-driven mechanism for cell-length sensing. Cell Reports , 1 (608-616)

Rohrer, JD; (2012) Structural brain imaging in frontotemporal dementia. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , 1822 (3) pp. 325-332. 10.1016/j.bbadis.2011.07.014.

Rohrer, JD; Clarkson, MJ; Kittus, R; Rossor, MN; Ourselin, S; Warren, JD; Fox, NC; (2012) Rates of Hemispheric and Lobar Atrophy in the Language Variants of Frontotemporal Lobar Degeneration. JOURNAL OF ALZHEIMERS DISEASE , 30 (2) pp. 407-411. 10.3233/JAD-2012-111556.

Rohrer, JD; Rossor, MN; Warren, JD; (2012) Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging , 33 (4) pp. 744-752. 10.1016/j.neurobiolaging.2010.05.020. Gold open access

Rohrer, JD; Sauter, D; Scott, S; Rossor, MN; Warren, JD; (2012) Receptive prosody in nonfluent primary progressive aphasias. Cortex , 48 (3) 308 - 316. 10.1016/j.cortex.2010.09.004. Gold open access

Rossor, M; (2012) Treatment and Management - a Major Challenge. In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. p. 5). KARGER

Ryan, N; Biessels, G; Bastos-Leite, A; Beck, J; Mead, S; Morris, H; Schott, JM; (2012) WHITE MATTER LESIONS IN FAMILIAL ALZHEIMER'S DISEASE: EVIDENCE FOR INFLUENCE OF MUTATION POSITION ON AMYLOID ANGIOPATHY? In:

Ryan, NS; Bastos-Leite, AJ; Rohrer, JD; Werring, DJ; Fox, NC; Rossor, MN; Schott, JM; (2012) Cerebral microbleeds in familial Alzheimer's disease. BRAIN , 135 (ARTN e20) 10.1093/brain/awr126.

S

Saccon, R; Joyce, P; Fratta, P; Greensmith, L; Acevedo, A; Fisher, EMC; (2012) Characterisation of a unique SOD1 mouse model for ALS. In: (Proceedings) UCL Institute of Neurology Student Symposium.

Scahill, RI; (2012) MRI BRAIN IMAGING AS A POTENTIAL MARKER FOR HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A5-A5). BMJ PUBLISHING GROUP

Scahill, RI; Wild, EJ; Tabrizi, SJ; (2012) Biomarkers for Huntington's disease: an update. Expert Opinion on Medical Diagnostics , 6 (5) 371 - 375. 10.1517/17530059.2012.701205. Green open access
file

Schott, J; Schrag, A; (2012) WHAT IS THE CLINICALLY RELEVANT CHANGE ON THE ADAS-COG? JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (3) 10.1136/jnnp-2011-301993.66.

Schott, JM; (2012) MRI BIOMARKERS IN NEURODEGENERATIVE DISORDERS. In: (Proceedings) 9th IEEE International Symposium on Biomedical Imaging (ISBI) - From Nano to Macro. (pp. p. 912). IEEE

Schott, JM; (2012) Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. NEUROBIOLOGY OF AGING , 33 (7) 10.1016/j.neurobiolaging.2011.02.008.

Schott, JM; (2012) Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging , 33 (7) 10.1016/j.neurobiolaging.2011.02.008.

Schott, JM; (2012) Voltage gated potassium channel complex antibody associated limbic encephalitis. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 817). WILEY-BLACKWELL

Schott, JM; Bartlett, JW; (2012) Investigating missing data in Alzheimer disease studies. NEUROLOGY , 78 (18) pp. 1370-1371. 10.1212/WNL.0b013e318253d66b.

Schott, JM; Warren, JD; (2012) Alzheimer's disease: mimics and chameleons. Pract Neurol , 12 (6) pp. 358-366. 10.1136/practneurol-2012-000315.

Schrag, A; Schott, JM; (2012) Kayser-Fleischer Rings in Wilson's Disease. NEW ENGLAND JOURNAL OF MEDICINE , 366 (12) E18-E18.

Schrag, A; Schott, JM; (2012) Kayser-Fleischer Rings in Wilson's Disease. NEW ENGLAND JOURNAL OF MEDICINE , 366 (12) E18-E18.

Schrag, A; Schott, JM; Alzheimer's Disease Neuroimaging Initiative, ; (2012) What is the clinically relevant change on the ADAS-Cog? J Neurol Neurosurg Psychiatry , 83 (2) pp. 171-173. 10.1136/jnnp-2011-300881.

Shakespeare, T; Crutch, S; (2012) EYE TRACKING IN POSTERIOR CORTICAL ATROPHY: A NEW INSIGHT INTO THE VISUAL SYNDROME. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Shakespeare, TJ; Crutch, SJ; Fox, NC; (2012) Posterior cortical atrophy: advice for diagnosis and implications for management. Neurodegenerative Disease Management , 2 (6) pp. 599-607. 10.2217/nmt.12.61.

Shakespeare, TJ; Ryan, NS; Petrushkin, H; Crutch, SJ; (2012) Identifying cortical visual dysfunction in posterior cortical atrophy. Optometry in Practice , 13 (4) pp. 159-162.

Sharma, H; Keshavan, A; Little, MA; Cross, J; Lipman, MC; Talukdar, S; Hopkins, S; (2012) Fortuitous vasculitis. Ren Fail , 34 (3) pp. 378-382. 10.3109/0886022X.2011.647337.

Sheppard, O; Wiseman, FK; Ruparelia, A; Tybulewicz, VLJ; Fisher, EMC; (2012) Mouse Models of Aneuploidy. SCIENTIFIC WORLD JOURNAL (ARTN 214) 10.1100/2012/214078. Gold open access

Silajdzic, E; Lahiri, N; Wild, EJ; Tabrizi, SJ; Bjorkqvist, M; (2012) A CRITICAL EVALUATION OF INFLAMMATORY MARKERS IN HUNTINGTON'S DISEASE PLASMA. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A23-A23). BMJ PUBLISHING GROUP

Sip, KE; Skewes, JC; Marchant, JL; McGregor, WB; Roepstorff, A; Frith, CD; (2012) What if I get busted? Deception, choice, and decision-making in social interaction. FRONTIERS IN NEUROSCIENCE , 6 (UNSP 58) 10.3389/fnins.2012.00058.

Sorbi, S; Hort, J; Erkinjuntti, T; Fladby, T; Gainotti, G; Gurvit, H; Nacmias, B; (2012) EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. EUROPEAN JOURNAL OF NEUROLOGY , 19 (9) 1159-+. 10.1111/j.1468-1331.2012.03784.x.

Sperling, R; Salloway, S; Brooks, DJ; Tampieri, D; Barakos, J; Fox, NC; Raskind, M; (2012) Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. LANCET NEUROLOGY , 11 (3) pp. 241-249. 10.1016/S1474-4422(12)70015-7.

Sprengelmeyer, R; Mueller, H-P; Suessmuth, SD; Groen, G; Hobbs, NZ; Cole, J; Roos, RAC; (2012) THE NEUROANATOMY OF DEPRESSION: EVIDENCE FROM HUNTINGTON'S DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A41-A42). BMJ PUBLISHING GROUP

Steckelberg, A-L; Boehm, V; Gromadzka, AM; Gehring, NH; (2012) CWC22 Connects Pre-mRNA Splicing and Exon Junction Complex Assembly. Cell Reports , 2 (3) pp. 454-461. 10.1016/j.celrep.2012.08.017.

Stout, JC; Jones, R; Labuschagne, I; O'Regan, AM; Say, MJ; Dumas, EM; Queller, S; (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (7) pp. 687-694. 10.1136/jnnp-2011-301940.

Suessmuth, SD; Landwehrmeyer, GB; Tabrizi, SJ; Andersen, C; DiBacco, M; Tripepi, G; Westerberg, G; (2012) A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IB PHARMACODYNAMIC STUDY WITH SELISISTAT (SEN0014196) IN HD PATIENTS. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A55-A55). BMJ PUBLISHING GROUP

T

Tabrizi, S; (2012) TRACK-HD AND TRACK-ON HD: YIELDING NEW INSIGHTS IN HUNTINGTON'S DISEASE. In:

Tabrizi, SJ; (2012) DEFINING PREDICTORS OF DISEASE. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A5-A5). BMJ PUBLISHING GROUP

Tabrizi, SJ; Reilmann, R; Roos, RAC; Durr, A; Leavitt, B; Owen, G; Jones, R; (2012) Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. LANCET NEUROLOGY , 11 (1) pp. 42-53. 10.1016/S1474-4422(11)70263-0.

Talano, MA; Busso, DC; Paisio, CE; González, PS; Purro, SA; Medina, MI; Agostini, E; (2012) Phytoremediation of 2,4-dichlorophenol using wild type and transgenic tobacco plants. Environ Sci Pollut Res Int , 19 (6) pp. 2202-2211. 10.1007/s11356-011-0724-9.

Trager, U; Andre, R; Lahiri, N; Magnusson, A; Pfister, E; Weiss, A; Grueninger, S; (2012) IMMUNE DYSFUNCTION IN HD HUMAN MYELOID CELLS IS CAUSED BY NFkB PATHWAY DYSREGULATION AND IS REVERSED BY LOWERING HTT LEVELS. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A12-A13). BMJ PUBLISHING GROUP

W

Warren, J; Rohrer, JD; Lashley, T; Schott, JM; Beck, J; Mead, S; Fox, NC; (2012) The frontotemporal lobar degenerations as 'molecular nexopathies'. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 258 - 259).

Warren, JD; Fletcher, PD; Golden, HL; (2012) The paradox of syndromic diversity in Alzheimer disease. NATURE REVIEWS NEUROLOGY , 8 (8) pp. 451-464. 10.1038/nrneurol.2012.135.

Warren, JD; Rohrer, JD; Hardy, J; (2012) Disintegrating Brain Networks: from Syndromes to Molecular Nexopathies. NEURON , 73 (6) pp. 1060-1062. 10.1016/j.neuron.2012.03.006. Gold open access

Watts, C; Brandner, S; (2012) Emerging Concepts in Neuro-Oncology. Springer

Weis, J; Brandner, S; Lammens, M; Sommer, C; Vallat, J-M; (2012) Processing of nerve biopsies: A practical guide for neuropathologists. CLINICAL NEUROPATHOLOGY , 31 (1) pp. 7-23. 10.5414/NP300468.

Weiss, A; Träger, U; Wild, EJ; Grueninger, S; Farmer, R; Landles, C; Scahill, RI; (2012) Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. Journal of Clinical Investigation , 122 (10) 3731 - 3736. 10.1172/JCI64565. Green open access
file

Westerberg, G; Diamanti, D; Pollio, G; Mori, E; Fondelli, C; Morena, E; Magnoni, L; (2012) SELISISTAT: POTENTIAL PHARMACODYNAMIC READOUTS BASED ON TRANSCRIPTOMICS. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A22-A22). BMJ PUBLISHING GROUP

Westerberg, G; Massai, L; Magnoni, L; Pollio, G; Tripepi, G; Diodato, E; Caricasole, A; (2012) SELISISTAT: SOLUBLE HTT PROTEIN LEVELS AS A POTENTIAL PHARMACODYNAMIC READOUT. In: (Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN). (pp. A21-A22). BMJ PUBLISHING GROUP

Weston, PS; Lim, CS; Shalhoub, J; Davies, AH; (2012) Metastatic bladder transitional cell carcinoma presenting as a vascularised cutaneous right arm lesion. Int J Clin Oncol , 17 (3) pp. 286-289. 10.1007/s10147-011-0282-7.

Wiggins, LM; Kuta, A; Stevens, JC; Fisher, EMC; von Bartheld, CS; (2012) A Novel Phenotype for the Dynein Heavy Chain Mutation Loa: Altered Dendritic Morphology, Organelle Density, and Reduced Numbers of Trigeminal Motoneurons. JOURNAL OF COMPARATIVE NEUROLOGY , 520 (12) pp. 2757-2773. 10.1002/cne.23085.

Wild, EJ; Carroll, JB; (2012) HDBuzz: empowering patients through accessible education. Trends in Molecular Medicine , 18 (1) 1 - 3. 10.1016/j.molmed.2011.09.003. Green open access
file

Wild, EJ; Tabrizi, SJ; (2012) Huntington’s disease. pp. 64-82. 10.1017/CBO9781139087711.006.

Wilkinson, D; Fox, NC; Barkhof, F; Phul, R; Lemming, O; Scheltens, P; (2012) Memantine and Brain Atrophy in Alzheimer's Disease: A 1-Year Randomized Controlled Trial. JOURNAL OF ALZHEIMERS DISEASE , 29 (2) pp. 459-469. 10.3233/JAD-2011-111616.

Wiseman, F; Sheppard, O; Barkus, C; Choong, X; Slender, A; Taylor, A; Bannerman, D; (2012) Trisomy of chromosome 21 modifies APP pathology in a mouse model. In: (Proceedings) Scottish TSE Network November Symposium.

Wray, S; Self, M; NINDS Parkinson's Disease iPSC Consortium, ; NINDS Huntington's Disease iPSC Consortium, ; NINDS ALS iPSC Consortium, ; Lewis, PA; Taanman, JW; (2012) Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLOS One , 7 (8) , Article e43099. 10.1371/journal.pone.0043099. Green open access
file

Z

Zadeh, G; Salehi, F; An, S; Uff, C; Camp, S; Revesz, T; Holton, J; (2012) Diagnostic implications of histological analysis of neurosurgical aspirate in addition to routine resections. NEUROPATHOLOGY , 32 (1) pp. 44-50. 10.1111/j.1440-1789.2011.01234.x.

This list was generated on Sun Dec 4 06:02:21 2016 GMT.